Gallstones during octreotide therapy.
Dowling
R H
RH
Gastroenterology Unit, UMDS of Guy's Hospitals, London, UK.
Hussaini
S H
SH
Murphy
G M
GM
Wass
J A
JA
D000172:Acromegaly / Q000150:complications; D000818:Animals; D001646:Bile / Q000737:chemistry; D002766:Cholecystokinin / Q000378:metabolism; D002769:Cholelithiasis / Q000139:chemically induced* / Q000737:chemistry / Q000453:epidemiology; D016473:Gallbladder Emptying / Q000187:drug effects; D006801:Humans; D015994:Incidence; D015282:Octreotide / Q000009:adverse effects* / Q000627:therapeutic use; D015995:Prevalence; D013004:Somatostatin / Q000502:physiology
D013004:Somatostatin; D002766:Cholecystokinin; D015282:Octreotide